THERESA MORTENSEN: Open Payments
NPI 1972683753 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 18 payments from 14 companies in 2025. Trend: 2023 $212 · 2024 $974 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 2 | $80 |
| Daiichi Sankyo Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: LYNOZYFIC, Enhertu, TAGRISSO, ICLUSIG, LIBTAYO, KISQALI, Onivyde, Nubeqa.
Industry payments across CA — which companies pay providers there.
